Obesity and nonalcoholic fatty liver disease.

@article{Angulo2007ObesityAN,
  title={Obesity and nonalcoholic fatty liver disease.},
  author={Paul Angulo},
  journal={Nutrition reviews},
  year={2007},
  volume={65 6 Pt 2},
  pages={
          S57-63
        }
}
  • P. Angulo
  • Published 1 June 2007
  • Medicine
  • Nutrition reviews
With the increasing prevalence of obesity and type 2 diabetes mellitus in the general population, nonalcoholic fatty liver disease (NAFLD) has become a common diagnosis in clinical practice. Insulin resistance and oxidative stress play an important role in NAFLD development and progression. NAFLD affects one in three adults and one in 10 children/adolescents in the United States. Mortality in patients with NAFLD is significantly higher than in the general population of same age and gender with… 
View on PubMed
encognitive.com
245 Citations
Highly Influential Citations
15
Background Citations
108
Methods Citations
4
Results Citations
1

245 Citations

Citation Type

Citation Type

Research advances in the relationship between nonalcoholic fatty liver disease and atherosclerosis
TLDR
This review aimed to summarize recent discoveries related to both NAFLD and atherosclerosis, and to identify possible mechanisms linking them.
Pediatric nonalcoholic fatty liver disease – a changing diagnostic paradigm
TLDR
A review of the main diagnosis tools in pediatric nonalcoholic fatty liver disease (NAFLD), a systemic disorder with multifactorial pathogenesis and varying clinical manifestations, emphasizes the use of noninvasive biomarkers and screening techniques for early diagnosis in children.
Nonalcoholic Fatty Liver Disease: Epidemiology, Pathogenesis, Natural History, Diagnosis, and Current Treatment Options.
TLDR
A summary of the epidemiology and pathogenesis of nonalcoholic fatty liver disease is presented, and the clinical evaluation and stratification of NAFLD patients into low, intermediate, and high risk with respect to liver-related outcomes are discussed.
Non-alcoholic Fatty Liver Disease and Type 2 Diabetes
TLDR
Because patients are usually asymptomatic and routine blood tests are often normal, non-alcoholic fatty liver disease may be a diagnosis that is overlooked in patients with type 2 diabetes.
Prevalence of non-alcoholic fatty liver disease in type 2 diabetes mellitus patients in a rural health care hospital
TLDR
An insight into the predisposing factors of NAFLD, revealed a higher prevalence of obesity, hypertension, hyperglycemia, hyperlipidemia and hyperuricemia in the subjects with NA FLD.
artical Non-alcoholic fatty liver disease ( NAFLD ) and immune response
TLDR
This review aims to update latest advances in epidemiology, clinical aspects, pathogenesis, mechanism, immune responses and therapies of non-alcoholic fatty liver disease (NAFLD), which is closely associated with metabolic syndrome, particularly obesity and insulin resistance.
Predictors of Non-Alcoholic Fatty Liver Disease in Egyptian Obese Adolescents
TLDR
Receiver– operating characteristic (ROC) curve analysis shows that ALT is a sensitive predictor for NAFLD, confirming that AlT can be used as a marker of NA FLD.
Hepatic lipid metabolism and non-alcoholic fatty liver disease.
Liver, Muscle, and Insulin Resistance in Obese Subjects: Exercise Effects
TLDR
It may be of great significance to practice exercise training for patients with chronic liver disease for improving the liver pathophysiology of NAFLD, as well as medical support of obese patients withNAFLD in Tsukuba University Hospital.
Molecular pathways in non-alcoholic fatty liver disease
TLDR
The molecular mechanisms that underlie the pathophysiological changes of hepatic lipid metabolism that contribute to non-alcoholic fatty liver disease are discussed.
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 29 REFERENCES
Treatment of non-alcoholic fatty liver disease
TLDR
Management of non-alcoholic fatty liver disease entails identification and treatment of metabolic risk factors, improving insulin sensitivity, and increasing antioxidant defences in the liver.
Treatment of nonalcoholic fatty liver disease.
NAFLD in children: A prospective clinical‐pathological study and effect of lifestyle advice
TLDR
It is concluded that children with NAFLD are almost always insulin‐resistant regardless of BMI, and obesity and older age are independently associated with increased liver fibrosis.
Steatosis: Co‐factor in other liver diseases
TLDR
In conclusion, active management of obesity and a reduction in steatosis may improve liver injury and decrease the progression of fibrosis.
Prevalence of and risk factors for nonalcoholic fatty liver disease: The Dionysos nutrition and liver study
TLDR
NAFLD is highly prevalent in the general population, is not associated with SLD, but is associated with many features of the metabolic syndrome.
Nonalcoholic fatty liver disease: an underrecognized cause of cryptogenic cirrhosis.
TLDR
Although there are no proven treatments, recommendations for patients with NAFLD include avoidance of hepatotoxins and aggressive management of associated conditions, such as hypertriglyceridemia and type 2 diabetes mellitus.
Prevalence of hepatic steatosis in an urban population in the United States: Impact of ethnicity
TLDR
The prevalence of hepatic steatosis was greater in men than women among whites, but not in blacks or Hispanics, and significant ethnic and sex differences in the prevalence may have a profound impact on susceptibility to Steatosis‐related liver disease.
The natural history of nonalcoholic fatty liver disease: a population-based cohort study.
TLDR
Mortality among community-diagnosed NAFLD patients is higher than the general population and is associated with older age, impaired fasting glucose, and cirrhosis, although the absolute risk is low.
The histological course of nonalcoholic fatty liver disease: a longitudinal study of 103 patients with sequential liver biopsies.
The characteristics and natural history of Japanese patients with nonalcoholic fatty liver disease.
...
1
2
3
...